guaifenesin and pseudoephedrine hydrochloride

Generic: guaifenesin and pseudoephedrine hydrochloride

Labeler: publix super markets, inc
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name guaifenesin and pseudoephedrine hydrochloride
Generic Name guaifenesin and pseudoephedrine hydrochloride
Labeler publix super markets, inc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

guaifenesin 600 mg/1, pseudoephedrine hydrochloride 60 mg/1

Manufacturer
PUBLIX SUPER MARKETS, INC

Identifiers & Regulatory

Product NDC 41415-994
Product ID 41415-994_a36d0524-b1d7-4daf-a62e-54f63168b0cd
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA212542
Listing Expiration 2026-12-31
Marketing Start 2022-04-07

Pharmacologic Class

Established (EPC)
expectorant [epc]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 41415994
Hyphenated Format 41415-994

Supplemental Identifiers

RxCUI
1305603
UNII
495W7451VQ 6V9V2RYJ8N
NUI
N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name guaifenesin and pseudoephedrine hydrochloride (source: ndc)
Generic Name guaifenesin and pseudoephedrine hydrochloride (source: ndc)
Application Number ANDA212542 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
  • 60 mg/1
source: ndc
Packaging
  • 1 BLISTER PACK in 1 CARTON (41415-994-18) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
  • 2 BLISTER PACK in 1 CARTON (41415-994-36) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
source: ndc

Packages (2)

Ingredients (2)

guaifenesin (600 mg/1) pseudoephedrine hydrochloride (60 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a36d0524-b1d7-4daf-a62e-54f63168b0cd", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "6V9V2RYJ8N"], "rxcui": ["1305603"], "spl_set_id": ["c857bcd9-6696-40d5-93c0-65097598cd4b"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["PUBLIX SUPER MARKETS, INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (41415-994-18)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "41415-994-18", "marketing_start_date": "20220407"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (41415-994-36)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "41415-994-36", "marketing_start_date": "20220407"}], "brand_name": "Guaifenesin and Pseudoephedrine Hydrochloride", "product_id": "41415-994_a36d0524-b1d7-4daf-a62e-54f63168b0cd", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "41415-994", "generic_name": "Guaifenesin and Pseudoephedrine Hydrochloride", "labeler_name": "PUBLIX SUPER MARKETS, INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin and Pseudoephedrine Hydrochloride", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "600 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "ANDA212542", "marketing_category": "ANDA", "marketing_start_date": "20220407", "listing_expiration_date": "20261231"}